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1. Introduction 
Disengagement from mental health services poses an important problem for people with 
psychosis. Lack of treatment adherence is associated with poorer physical health, reduced 
social functioning, an increased rate of relapse and an increased likelihood of being legally 
detained (O'Brien et al., 2009). Previous research has uncovered differences in treatment 
beliefs based upon either differences in causal attributions (McCabe, 2004) and ethnic/racial 
group (Jimenez et al., 2012), however the impact of differing treatment beliefs on 
engagement in care has not been examined. This is an important extension since if it can be 
evidenced that differing treatment beliefs are associated with variation in engagement, 
services may seek to realign to account for these differences. We aimed to complete a 
secondary analysis of a pre-existing cohort to examine; 1) whether different treatment beliefs 
were associated with engagement in care; 2) the influence of sociodemographic differences 
on treatment beliefs and whether these differences extended to engagement in care. 
2. Methods 
This study was part of the NIHR funded U.K. based ENRICH Programme. Methodological 
specifics have been reported in detail elsewhere (Singh et al., 2013). We used the Beliefs 
about Treatments for Mental Illness (BATMI) scale to explore patient’s beliefs about what is 
the appropriate treatment for mental illness (Furnham and Wong, 2007). BATMI categorizes 
treatment beliefs into six categories: biological; psychotherapeutic; community; alternative; 
religious; and supernatural. SOLES (Singh O’Brien Level of Engagement Scale) was used to 
measure service user engagement with mental health services (O'Brien et al., 2009). We used 
both a continuous and a binary measure for SOLES, with the binary measure categorizing 
participants into either “high engagement” (score ≥5 on SOLES), or low engagement (score 
<5 on SOLES). Adjustments for potential confounding variables were made in two stages; 
age (at assessment; continuous), sex (categorical), and education level (categorical); and then;  
ethnicity (categorical) and religion (categorical). 
 
Univariable Pearson’s correlation analyses were performed on the BATMI categories and 
SOLES. For the continuous SOLES measure, we then performed linear regression analyses 
with and without adjustments. For the binary SOLES measure, we used logistic regression, 
with and without adjustments. Statistical analysis was completed using IBM SPSS Statistics 
24.0. 
 
3. Results 
Our sample size was n=98; age range 14-37 years. Sample characteristics are described in 
supplementary data table 1. Demographics were similar between participants, though a 
difference was noted in educational level (p=0.01). 
 
For the continuous SOLES measure, there were positive univariable correlations for 
biological (r=0.30, p<0.01), psychological (r=0.28, p<0.01) and community (r=0.34, p<0.01) 
treatment beliefs. For the binary SOLES measure, there were positive univariable correlations 
for biological (r=0.30, p<0.01), psychological (r=0.28, p<0.01) and community (r=0.31, 
p<0.01) treatment beliefs. Our multivariable linear regression analyses (table 1) and logistic 
regression analyses (supplementary data table 2) echoed those associations, before and after 
adjustments, with little attenuation. 
 
 
 
 4. Discussion 
We found that biological, psychological and community-based treatment beliefs were 
significant predictors of engagement. This may echo the bio-psycho-social model of 
treatment delivery, commonly used in the U.K. Biological treatment beliefs have previously 
shown to be associated with greater satisfaction and adherence to treatment (Wiesjahn et al., 
2014).  An important strength of the BATMI measure is that it captures strength of belief, 
with a higher score relating to a higher strength of belief. We are therefore able, to some 
extent, to show a ‘dose-response’ relationship between treatment beliefs and engagement in 
care. We also found that ethnicity and religion did not alter the associations between 
treatment beliefs and engagement, and that there were no associations between religious, 
superstitious or alternative treatment beliefs and engagement. Holding such treatment beliefs 
has in previous research not reduced confidence in the medical model of treatment received 
for mental illness (Charles et al., 2007; Conrad et al., 2007). Our limitations include the 
cross-sectional design of the study, which is inherently susceptible to reverse causality and 
residual confounding. Additionally, we were unable to include measures such as the adverse 
effects of medication or availability of healthcare, which have been shown to affect 
engagement (Dixon et al., 2016).  
Table 1: Linear Regression Analysis for BATMI categories and SOLES 
Predictor Regression Co-efficient (S.E.) for SOLES 
BATMI categories Unadjusted Model Adjusted for age, sex, 
education 
+ ethnicity & religion 
 n B (S.E.) p B (S.E.) p B (S.E.) P 
Biological 
Alt Med 
Psychological 
Community 
Religious 
Superstitious 
98 
98 
98 
98 
98     
98 
  0.31 (0.02) 
  0.12 (0.04) 
  0.34 (0.03) 
  0.33 (0.04) 
  0.10 (0.04) 
  0.08 (0.02)     
 <0.001* 
  0.174 
<0.001* 
<0.001* 
  0.364 
  0.345 
0.32 (0.03) 
0.13 (0.05) 
0.32 (0.05) 
0.31 (0.04)  
0.08 (0.07) 
0.10 (0.06) 
0.002* 
0.174 
0.001* 
0.008* 
0.455 
0.343 
0.32 (0.05) 
0.20 (0.05) 
0.32 (0.06) 
0.32 (0.06) 
0.14 (0.07) 
0.09 (0.04) 
0.003* 
0.244 
0.008* 
0.004* 
0.228 
0.156 
*indicates p<0.05 
Overall, our findings suggest that stronger beliefs in the bio-psycho-social model of mental 
healthcare, which is the generally accepted treatment model in the U.K., is predictive of 
higher engagement in care. This effect withstood adjustment for multiple possible 
confounders. Clinicians and other healthcare professionals may be encouraged to place 
greater emphasis on ensuring adequate explanations, tailored to the individual, of the 
scientific basis and intended effects behind prescribed treatments, whether biological, 
psychological or social.  
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